Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Nuclear Receptor/Transcription Factor-Eukaryotic Initiation Factor (eIF)-HR-19011
HR-19011

Chemical Structure : HR-19011

CAS No.: 2851820-52-3

HR-19011 (HR19011)

Catalog No.: PC-24545Not For Human Use, Lab Use Only.

HR-19011 is a specific small molecule eIF2α phosphorylation inducer, increases the expression level of eIF2α downstream proteins, ATF and CHOP, shows antiproliferation in K562 cells with IC50 of 4.0 uM.

Packing Price Stock Quantity
5 mg $128 In stock
10 mg $198 In stock
25 mg $328 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

Welcome credit card payment!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

HR-19011 is a specific small molecule eIF2α phosphorylation inducer, increases the expression level of eIF2α downstream proteins, ATF and CHOP, shows antiproliferation in K562 cells with IC50 of 4.0 uM.
HR-19011 exerts anticancer effects primarily through the activation of heme-regulated inhibitor (HRI), leading to the phosphorylation of eukaryotic translation initiation factor 2 (eIF2)α.
HR-19011 exhibits remarkably high selectivity index over PBMC cells.
HR-19011 increases the expression level of eIF2α downstream proteins, ATF and CHOP.
HR-19011 suppresses the mTORC1 pathway, a critical regulator of cell growth and metabolism, through the downregulation of components such as phosphorylated (p)-S6K and p-4EBP1, mediated by ATF4 and CHOP.
HR-19011 effectively inhibits tumor growth in a K562 xenograft model, without significant toxicity.

Physicochemical Properties

M.Wt 523.44
Formula C25H19F6N3O3
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

3-((3,4-dioxo-2-(((1r,4r)-4-(4-(trifluoromethyl)phenoxy)cyclohexyl)amino)cyclobut-1-en-1-yl)amino)-5-(trifluoromethyl)benzonitrile

References

1. Jinsook Kwak, et al. Eur J Med Chem. 2022 May 29;239:114501.

2. Kim MJ, et al. Mol Cancer Ther. 2025 Apr 28. doi: 10.1158/1535-7163.MCT-24-0998.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: